{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:31:29Z","timestamp":1768566689317,"version":"3.49.0"},"posted":{"date-parts":[[2024,1,4]]},"group-title":"Genetic and Genomic Medicine","reference-count":62,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>\n                    GM1 gangliosidosis (GM1) is an ultra-rare lysosomal storage disease caused by pathogenic variants in galactosidase beta 1 (\n                    <jats:italic>GLB1<\/jats:italic>\n                    ; NM_000404), primarily characterized by neurodegeneration, often in children. There are no approved treatments for GM1, but clinical trials using gene therapy (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03952637\">NCT03952637<\/jats:ext-link>\n                    ,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04713475\">NCT04713475<\/jats:ext-link>\n                    ) and small molecule substrate inhibitors (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04221451\">NCT04221451<\/jats:ext-link>\n                    ) are ongoing. Understanding the natural history of GM1 is essential for timely diagnosis, facilitating better supportive care, and contextualizing the results of therapeutic trials.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Forty-one individuals with type II GM1 (n=17 late infantile and n=24 juvenile onset) participated in a single-site prospective observational study. Here, we describe the results of extensive multisystem assessment batteries, including clinical labs, neuroimaging, physiological exams, and behavioral assessments.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Classification of 37 distinct variants in this cohort was performed according to ACMG criteria and resulted in the upgrade of six and the submission of four new variants to pathogenic or likely pathogenic. In contrast to type I infantile, children with type II disease exhibited normal or near normal hearing and did not have cherry red maculae or significant hepatosplenomegaly. Some older children with juvenile onset developed thickened aortic and\/or mitral valves with regurgitation. Serial MRIs demonstrated progressive brain atrophy that were more pronounced in those with late infantile onset. MR spectroscopy showed worsening elevation of myo-inositol and deficit of\n                    <jats:italic>N<\/jats:italic>\n                    -acetyl aspartate that were strongly correlated with scores on the Vineland Adaptive Behavior Scale and progress more rapidly in late infantile than juvenile onset disease.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The comprehensive serial phenotyping of type II GM1 patients expands the understanding of disease progression and clarifies some common misconceptions about type II patients. Findings from this 10-year endeavor are a pivotal step toward more timely diagnosis and better supportive care for patients. The wealth of data amassed through this effort will serve as a robust comparator for ongoing and future therapeutic trials.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.01.04.24300778","type":"posted-content","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T01:44:11Z","timestamp":1704851051000},"source":"Crossref","is-referenced-by-count":1,"title":["GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study"],"prefix":"10.64898","author":[{"given":"Precilla","family":"D\u2019Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristan","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangwoo T","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam L.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wadih","family":"Zein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laryssa A.","family":"Huryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Myles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena-Raluca","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline E","family":"Rothermel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoliann","family":"Mojica Algarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Quimby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosufa","family":"Zainab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashura","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Regier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"V\u00e9zina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Thurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia J","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"3","key":"2024010921463235000_2024.01.04.24300778v1.1","first-page":"566","article-title":"GM1-gangliosidosis (genetic beta-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients","volume":"49","year":"1991","journal-title":"American Journal of Human Genetics"},{"key":"2024010921463235000_2024.01.04.24300778v1.2","unstructured":"Regier DS , Tifft CJ. GLB1-Related Disorders (Updated 2021). In: Adam MP , Ardinger HH , Pagon RA , et al, eds. GeneReviews(\u00ae). University of Washington, Seattle Copyright \u00a9 1993-2020, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 2013."},{"key":"2024010921463235000_2024.01.04.24300778v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.04.012"},{"key":"2024010921463235000_2024.01.04.24300778v1.4","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1965.02090020340014"},{"key":"2024010921463235000_2024.01.04.24300778v1.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.160.3831.1002"},{"key":"2024010921463235000_2024.01.04.24300778v1.6","unstructured":"Regier DS , Tifft CJ. GLB1-Related Disorders. In: Adam MP , Ardinger HH , Pagon RA , et al, eds. GeneReviews. University of Washington, Seattle; 2013."},{"key":"2024010921463235000_2024.01.04.24300778v1.7","doi-asserted-by":"publisher","DOI":"10.1159\/000112201"},{"key":"2024010921463235000_2024.01.04.24300778v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.03.018"},{"key":"2024010921463235000_2024.01.04.24300778v1.9","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-015-0593-2"},{"issue":"5","key":"2024010921463235000_2024.01.04.24300778v1.10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/cge.14005","article-title":"Lysosomal storage disorders as an etiology of nonimmune hydrops fetalis: A systematic review","volume":"100","year":"2021","journal-title":"Clinical Genetics"},{"key":"2024010921463235000_2024.01.04.24300778v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.08.016"},{"key":"2024010921463235000_2024.01.04.24300778v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2017.04.011"},{"key":"2024010921463235000_2024.01.04.24300778v1.13","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2015_451"},{"key":"2024010921463235000_2024.01.04.24300778v1.14","doi-asserted-by":"publisher","DOI":"10.1097"},{"issue":"6","key":"2024010921463235000_2024.01.04.24300778v1.15","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0021-9258(19)42862-7","article-title":"The structures of oligosaccharides accumulating in the liver of G-M1-gangliosidosis, type I","volume":"249","year":"1974","journal-title":"Journal of Biological Chemistry"},{"key":"2024010921463235000_2024.01.04.24300778v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2017.12.432"},{"issue":"5","key":"2024010921463235000_2024.01.04.24300778v1.17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4274\/balkanmedj.galenos.2022.2022-3-75","article-title":"Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients","volume":"39","year":"2022","journal-title":"Balkan Medical Journal"},{"key":"2024010921463235000_2024.01.04.24300778v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.12.012"},{"issue":"5","key":"2024010921463235000_2024.01.04.24300778v1.19","first-page":"367","article-title":"Fetal Homozygous GM1 Gangliosidosis Presenting as Transient Non-immune Hydrops Fetalis","volume":"25","year":"2023","journal-title":"Israel Medical Association Journal"},{"key":"2024010921463235000_2024.01.04.24300778v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-444-59565-2.00039-3"},{"key":"2024010921463235000_2024.01.04.24300778v1.21","doi-asserted-by":"publisher","DOI":"10.1002\/jmd2.12067"},{"key":"2024010921463235000_2024.01.04.24300778v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310316"},{"key":"2024010921463235000_2024.01.04.24300778v1.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-018-0315-2"},{"key":"2024010921463235000_2024.01.04.24300778v1.24","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-017-0417-4"},{"key":"2024010921463235000_2024.01.04.24300778v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2018.01.009"},{"key":"2024010921463235000_2024.01.04.24300778v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.08.016"},{"issue":"Suppl 1","key":"2024010921463235000_2024.01.04.24300778v1.27","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: natural history and progress toward therapy","volume":"13","year":"2016","journal-title":"Pediatric endocrinology reviews: PER"},{"key":"2024010921463235000_2024.01.04.24300778v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115142"},{"issue":"5","key":"2024010921463235000_2024.01.04.24300778v1.29","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/jimd.12646","article-title":"Natural history of GM1 gangliosidosis-Retrospective cohort study of 61 French patients from 1998 to 2019","volume":"46","year":"2023","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"Suppl 1","key":"2024010921463235000_2024.01.04.24300778v1.30","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: natural history and progress toward therapy","volume":"13","year":"2016","journal-title":"Pediatric Endocrinology Reviews"},{"key":"2024010921463235000_2024.01.04.24300778v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2024010921463235000_2024.01.04.24300778v1.32","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23626"},{"key":"2024010921463235000_2024.01.04.24300778v1.33","unstructured":"Biesecker LG. Personal communication. 2023."},{"key":"2024010921463235000_2024.01.04.24300778v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.210"},{"key":"2024010921463235000_2024.01.04.24300778v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24088"},{"key":"2024010921463235000_2024.01.04.24300778v1.36","unstructured":"National Library of Medicine. ClinVar Database. Accessed October 2023, https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/?term=GLB1%5Bgene%5D&redir=gene"},{"key":"2024010921463235000_2024.01.04.24300778v1.37","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13492"},{"issue":"17","key":"2024010921463235000_2024.01.04.24300778v1.38","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.3390\/ijms241713239","article-title":"Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement","volume":"24","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"4 Suppl. 2","key":"2024010921463235000_2024.01.04.24300778v1.39","first-page":"107","article-title":"Cardiac involvement in Lysosomal Storage Diseases","volume":"34","year":"2020","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"key":"2024010921463235000_2024.01.04.24300778v1.40","doi-asserted-by":"crossref","unstructured":"Mandato C , Vajro P . Isolated aspartate aminotransferase elevation: Is it liver disease or what else? : Wiley Online Library; 2022. p. 459\u2013461.","DOI":"10.1111\/apa.16213"},{"issue":"3","key":"2024010921463235000_2024.01.04.24300778v1.41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/apa.16123","article-title":"The significance of isolated aspartate aminotransferase elevation in healthy paediatric patients","volume":"111","year":"2022","journal-title":"Acta Paediatrica"},{"key":"2024010921463235000_2024.01.04.24300778v1.42","doi-asserted-by":"crossref","unstructured":"Kasai A , Motobayashi M , Nishioka M , Fukuyama T , Inaba Y . A serial analysis of serum aspartate aminotransferase levels in patients with acute encephalopathy with biphasic seizures and late reduced diffusion and prolonged febrile seizure. Brain and Development. 2023;","DOI":"10.1016\/j.braindev.2023.06.003"},{"key":"2024010921463235000_2024.01.04.24300778v1.43","doi-asserted-by":"publisher","DOI":"10.1177\/01926233231201408"},{"key":"2024010921463235000_2024.01.04.24300778v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(92)90361-2"},{"key":"2024010921463235000_2024.01.04.24300778v1.45","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.163"},{"issue":"12","key":"2024010921463235000_2024.01.04.24300778v1.46","doi-asserted-by":"crossref","first-page":"e83455","DOI":"10.1371\/journal.pone.0083455","article-title":"Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"2024010921463235000_2024.01.04.24300778v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2014.02.002"},{"key":"2024010921463235000_2024.01.04.24300778v1.48","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12269"},{"key":"2024010921463235000_2024.01.04.24300778v1.49","doi-asserted-by":"publisher","DOI":"10.1177\/0194599814529081"},{"issue":"2","key":"2024010921463235000_2024.01.04.24300778v1.50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1044\/2018_AJSLP-18-0072","article-title":"Comparative validity of the American Speech-Language-Hearing Association\u2019s national outcomes measurement system, functional oral intake scale, and G-codes to mann assessment of swallowing ability scores for dysphagia","volume":"28","year":"2019","journal-title":"American Journal of Speech-Language Pathology"},{"key":"2024010921463235000_2024.01.04.24300778v1.51","doi-asserted-by":"publisher","DOI":"10.1007\/BF00417897"},{"key":"2024010921463235000_2024.01.04.24300778v1.52","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910300604"},{"key":"2024010921463235000_2024.01.04.24300778v1.53","doi-asserted-by":"publisher","DOI":"10.1006\/jmrb.1993.1055"},{"key":"2024010921463235000_2024.01.04.24300778v1.54","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh467"},{"issue":"8","key":"2024010921463235000_2024.01.04.24300778v1.55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acn3.222","article-title":"Evaluation of disease progression in INCL by MR spectroscopy","volume":"2","year":"2015","journal-title":"Annals of clinical and translational neurology"},{"issue":"3","key":"2024010921463235000_2024.01.04.24300778v1.56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jmri.21285","article-title":"Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 Tesla","volume":"27","year":"2008","journal-title":"Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine"},{"issue":"3","key":"2024010921463235000_2024.01.04.24300778v1.57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mrm.10242","article-title":"Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging","volume":"48","year":"2002","journal-title":"Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine"},{"key":"2024010921463235000_2024.01.04.24300778v1.58","doi-asserted-by":"crossref","unstructured":"Sparrow SS , Cicchetti DV , Balla DA. Vineland Adaptive Behavior Scales, Second Edition. AGS Publishing; 2005.","DOI":"10.1037\/t15164-000"},{"key":"2024010921463235000_2024.01.04.24300778v1.59","unstructured":"Sparrow SS , Cicchetti DV , Saulnier CA . Vineland-3: Vineland adaptive behavior scales. PsychCorp; 2016."},{"issue":"1","key":"2024010921463235000_2024.01.04.24300778v1.60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/jir.12691","article-title":"Concordance of the Vineland Adaptive Behavior Scales, second and third editions","volume":"64","year":"2020","journal-title":"Journal of Intellectual Disability Research"},{"key":"2024010921463235000_2024.01.04.24300778v1.61","doi-asserted-by":"crossref","unstructured":"Farmer C, A.J. K , Berry-Kravis E , Thurm A. Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder. In: Esbensen A , Schworer E , eds. International Review of Research in Developmental Disabilities. Elsevier Inc. Academic Press; 2022:1\u201339.","DOI":"10.1016\/bs.irrdd.2022.05.001"},{"key":"2024010921463235000_2024.01.04.24300778v1.62","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-022-09474-6"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.01.04.24300778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:47:45Z","timestamp":1768506465000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.01.04.24300778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":62,"URL":"https:\/\/doi.org\/10.1101\/2024.01.04.24300778","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.gim.2024.101144","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,1,4]]},"subtype":"preprint"}}